Honggang Zhou (Wenqi Li)

Years Active: 2023-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Jianwei Zhang, Xiujun Zhang, Xiaowei Guo, Wenqi Li, Tiantian Zhang, Dan Chai, Yuming Liu, Li Chen, Xiaoyu Ai, Tianyuan Zhou, Wenguo Wei, Xiaoting Gu, Xiaohe Li, Honggang Zhou
Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway. PloS one 19 (7) (2024)
Jianwei Zhang, Xiujun Zhang, Xiaowei Guo, Wenqi Li, Tiantian Zhang, Dan Chai, Yuming Liu, Li Chen, Xiaoyu Ai, Tianyuan Zhou, Wenguo Wei, Xiaoting Gu, Xiaohe Li, Honggang Zhou
Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway. PloS one 19 (7) (2024)
Jianwei Zhang, Xiujun Zhang, Xiaowei Guo, Wenqi Li, Tiantian Zhang, Dan Chai, Yuming Liu, Li Chen, Xiaoyu Ai, Tianyuan Zhou, Wenguo Wei, Xiaoting Gu, Xiaohe Li, Honggang Zhou
Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway. PloS one 19 (7) (2024)
Honggang Zhou, Shuwen Zhu, Jing Liu, Zhigang Liu, Hong-Gang Zhou, Qianyi Zhang, Yue Yang, Li Chen, Xiaowei Guo, Tiantian Zhang, Lingxin Meng, Dan Chai, Guodong Tang, Xiaohe Li, Cheng Yang
Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules (Basel, Switzerland) 28 (16) (2023)

Honggang Zhou.css-eqlu8i{font-size:small;padding-left:4px;} (Wenqi Li)